Wide-field optical coherence tomography based microangiography for retinal imaging
- PMID: 26912261
- PMCID: PMC4766473
- DOI: 10.1038/srep22017
Wide-field optical coherence tomography based microangiography for retinal imaging
Abstract
Optical coherence tomography angiography (OCTA) allows for the evaluation of functional retinal vascular networks without a need for contrast dyes. For sophisticated monitoring and diagnosis of retinal diseases, OCTA capable of providing wide-field and high definition images of retinal vasculature in a single image is desirable. We report OCTA with motion tracking through an auxiliary real-time line scan ophthalmoscope that is clinically feasible to image functional retinal vasculature in patients, with a coverage of more than 60 degrees of retina while still maintaining high definition and resolution. We demonstrate six illustrative cases with unprecedented details of vascular involvement in retinal diseases. In each case, OCTA yields images of the normal and diseased microvasculature at all levels of the retina, with higher resolution than observed with fluorescein angiography. Wide-field OCTA technology will be an important next step in augmenting the utility of OCT technology in clinical practice.
Conflict of interest statement
RKW received research support from Carl Zeiss Meditec, Inc. TZ, US were employed by Carl Zeiss Meditec, Inc. RKW and the Oregon Health & Science University co-own a patent that is related to the subject matter discussed in this manuscript. RKW received an innovative research award from Research to Prevent Blindness. MJ is a consultant for Healonics, Sensimed, Ivantis, Cascade Ophthalmics, and receives royalties from intellectual property owned by Allergan. QQ, CL, JC, CC, AZ, JL, KR, KP, RM, JK, and RVG: None.
Figures
References
-
- Keane P. A., Mand P. S., Liakopoulos S., Walsh A. C. & Sadda S. R. Accuracy of retinal thickness measurements obtained with Cirrus optical coherence tomography. Br J Ophthalmol 93, 1461–1467 (2009). - PubMed
-
- Rofagha S. et al. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 120, 2292–2299 (2013). - PubMed
-
- Brown D. M. et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 120, 2013–2022 (2013). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
